SNTI · NASDAQ
Senti Biosciences Holdings (SNTI) Stock Price & Fundamentals
Senti Biosciences Holdings (SNTI) closed at $783.73 on Oct 9, 2026, down 0.05% from the previous close of $784.10.
Share price, past year
1Y +14.70%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $783.73 |
| Sep 30, 2026 | $795.82 |
| Aug 31, 2026 | $804.09 |
| Jul 31, 2026 | $799.25 |
| Jun 30, 2026 | $778.17 |
| May 29, 2026 | $756.76 |
| Apr 30, 2026 | $806.30 |
| Mar 31, 2026 | $771.49 |
| Feb 27, 2026 | $735.32 |
| Jan 30, 2026 | $716.13 |
| Dec 31, 2025 | $694.16 |
| Nov 28, 2025 | $682.92 |
| Oct 31, 2025 | $702.13 |
Key statistics
- Market cap
- $24.41B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.31
- Revenue (TTM)
- —
- Net income (TTM)
- −$49.56M
- Shares outstanding
- 31.1M
- Dividend yield
- —
- 52-week range
- $666.40 – $831.79
Senti Biosciences Holdings's market cap is $24.41B, based on a share price of $783.73 and 31.1M shares outstanding as of Jun 30, 2026.
Financials
Senti Biosciences Holdings reported revenue of $22.00K for fiscal 2025.
Senti Biosciences Holdings reported a net loss of $61.44M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $22.00K | — | −$61.44M | −279,263.6% | −$2.73 | −$43.64M |
| FY2024ended Dec 31, 2024 | $0.00 | −100.0% | −$52.79M | — | −$12.03 | −$41.42M |
| FY2023ended Dec 31, 2023 | $2.56M | −40.3% | −$71.06M | −2,774.6% | −$16.01 | −$64.43M |
| FY2022ended Dec 31, 2022 | $4.29M | +55.2% | −$58.21M | −1,358.1% | −$22.30 | −$76.27M |
| FY2021ended Dec 31, 2021 | $2.76M | — | −$55.32M | −2,003.6% | −$190.00 | −$40.18M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $17.00K | −$12.75M | −$0.41 |
| Q1 FY2026ended Mar 31, 2026 | $16.00K | −$4.22M | −$0.14 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$14.73M | −$0.56 |
| Q1 FY2025ended Mar 31, 2025 | $0.00 | −$14.11M | −$1.41 |
| Q4 FY2024ended Dec 31, 2024 | $0.00 | −$610.00K | −$0.62 |
| Q3 FY2024ended Sep 30, 2024 | $0.00 | −$28.87M | −$6.31 |
| Q2 FY2024ended Jun 30, 2024 | $0.00 | — | — |
| Q1 FY2024ended Mar 31, 2024 | $0.00 | — | — |
Company profile
- Name
- Senti Biosciences Holdings, Inc.
- Ticker
- SNTI
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 2 Corporate Drive, First Floor, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001854270
Recent SEC filings
- Sep 24, 2026
- Sep 4, 2026
- Sep 2, 2026
- Aug 20, 2026
- Aug 14, 2026
- Jul 15, 2026
- May 26, 2026
- May 14, 2026
Frequently asked questions
What is Senti Biosciences Holdings's stock price?
Senti Biosciences Holdings (SNTI) closed at $783.73 on Oct 9, 2026, down 0.05% from the previous close of $784.10.
What is Senti Biosciences Holdings's market cap?
Senti Biosciences Holdings's market cap is $24.41B, based on a share price of $783.73 and 31.1M shares outstanding as of Jun 30, 2026.
How much revenue does Senti Biosciences Holdings make?
Senti Biosciences Holdings reported revenue of $22.00K for fiscal 2025.
Does Senti Biosciences Holdings pay a dividend?
Senti Biosciences Holdings's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Senti Biosciences Holdings, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures